These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23072848)

  • 1. Drug use evaluation of diabetes mellitus in hospitalized patients of a tertiary care referral hospital.
    Khalam A; Dilip C; Shinu C
    J Basic Clin Physiol Pharmacol; 2012; 23(4):173-7. PubMed ID: 23072848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription pattern of antidiabetic drugs in the outpatient departments of hospitals in Malappuram district, Kerala.
    Shamna M; Karthikeyan M
    J Basic Clin Physiol Pharmacol; 2011 Sep; 22(4):141-3. PubMed ID: 22865436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of emergency department and outpatient visits for hypoglycemia in type 2 diabetes: an analysis of a large US administrative claims database.
    Simeone JC; Quilliam BJ
    Ann Pharmacother; 2012 Feb; 46(2):157-68. PubMed ID: 22234990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L; Köster I; Hauner H
    Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug utilization pattern and effectiveness analysis in diabetes mellitus at a tertiary care centre in eastern Nepal.
    Das P; Das BP; Rauniar GP; Roy RK; Sharma SK
    Indian J Physiol Pharmacol; 2011; 55(3):272-80. PubMed ID: 22471235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice.
    Matsuyama-Yokono A; Tahara A; Nakano R; Someya Y; Shiraki K; Hayakawa M; Shibasaki M
    Metabolism; 2009 Mar; 58(3):379-86. PubMed ID: 19217455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prescribing behavior of primary care physicians in diabetes therapy: effect of drug budgeting].
    Jünger C; Rathmann W; Giani G
    Dtsch Med Wochenschr; 2000 Feb; 125(5):103-9. PubMed ID: 10705882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the use of oral antidiabetic drugs by outpatients in Taiwan: 1997-2003.
    Chiang CW; Chiu HF; Chen CY; Wu HL; Yang CY
    J Clin Pharm Ther; 2006 Feb; 31(1):73-82. PubMed ID: 16476123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in antidiabetic medication intensity among Medicare beneficiaries with diabetes mellitus.
    Stuart B; Shaffer TJ; Simoni-Wastila LJ; Zuckerman IH; Quinn CC
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):195-208. PubMed ID: 17996659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the prescription and cost of diabetic medications and monitoring equipment in England 1991-2004.
    Patel H; Srishanmuganathan J; Car J; Majeed A
    J Public Health (Oxf); 2007 Mar; 29(1):48-52. PubMed ID: 17124257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database.
    Zhang Q; Rajagopalan S; Mavros P; Engel SS; Davies MJ; Yin D; Radican L
    Curr Med Res Opin; 2010 Jul; 26(7):1697-703. PubMed ID: 20465367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of drug therapy and risk factors in diabetic hypertensives: a study of the quality of care provided in diabetic clinics in Bahrain.
    Al Khaja KA; P Sequeira R; Damanhori AH
    J Eval Clin Pract; 2005 Apr; 11(2):121-31. PubMed ID: 15813710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B; Raccah D; Cadilhac M; Eschwège E
    Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997-2003.
    Chiang CW; Chen CY; Chiu HF; Wu HL; Yang CY
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):412-21. PubMed ID: 17252613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas.
    Shorr RI; Ray WA; Daugherty JR; Griffin MR
    Arch Intern Med; 1997 Aug 11-25; 157(15):1681-6. PubMed ID: 9250229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of drug usage and expenditure in a hospital diabetes clinic.
    Wu SY; Lung BC; Chang S; Lee SC; Critchley JA; Chan JC
    J Clin Pharm Ther; 1998 Feb; 23(1):49-56. PubMed ID: 9756112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidiabetic agents: past, present and future.
    Mehanna A
    Future Med Chem; 2013 Mar; 5(4):411-30. PubMed ID: 23495689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing hyperglycemia in patients with type 2 diabetes mellitus: rationale for the use of dipeptidyl peptidase-4 inhibitors in combination with other oral antidiabetic drugs.
    Freeman JS
    J Am Osteopath Assoc; 2010 Sep; 110(9):528-37. PubMed ID: 20876838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.